1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Motor neurone disease

Guidance on the use of Riluzole (Rilutek) for the treatment of Motor Neurone Disease

Technology appraisal guidance [TA20] Published: 23 January 2001

  • Guidance
  • Tools and resources
  • Information for the public
  • History

History

A list of downloadable documents created during development.

Other information

  • TA20 Motor neurone disease - riluzole: guidance (html) information  

Background information

  • Motor neurone disease - riluzole: Static List Review Decision - April 2014 information  
  • Appendix A -Static List Review paper PDF 185 KB 01 April 2014  
  • Riluzole for Motor Neurone Disease - HTA report part 1 PDF 833 KB 22 January 2001  
  • Riluzole for Motor Neurone Disease - HTA report part 2 PDF 31 KB 22 January 2001  
  • Riluzole - Appeal against guidance dated December 2000 information  
  • Review of TA20 Riluzole for the treatment of motor neurone disease  information  
  • Review proposal MSWord 37 KB 06 February 2006  
  • Review decision information